Xenetic Biosciences, Inc.

menu

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Technology
    • Overview
    • XCART Platform
    • PolyXen™
    • Publications
  • Product Pipeline
    • Overview
    • XCART
    • PolyXen™
  • News & Media
    • Press Releases
    • Presentations
    • Multimedia
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Proxy Materials
    • Proxy Materials
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Governance Documents
  • Contact
  • Xenetic Biosciences, Inc. on Twitter
  • Xenetic Biosciences, Inc. on Facebook
  • Xenetic Biosciences, Inc. on LinkedIn
Nasdaq: XBIO
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Information
    • Financials
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • Proxy Materials
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
05/13/19 S-4/A Registration of securities issued in business combination transactions
Related Documents
EX-5.1
EX-23.1
EX-99.2
415
05/13/19 8-K/A Current report filing
Related Documents
EX-2.1
EX-10.1
165
05/13/19 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Related Documents
EX-2.1
EX-10.1
165
05/13/19 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions 3
05/13/19 8-K Current report filing
Related Documents
EX-99.1
7
05/13/19 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
29
04/30/19 10-K/A Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-31.3
EX-31.4
21
04/24/19 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 3
04/12/19 UPLOAD SEC-generated letter
Related Documents
TEXT-EXTRACT
2
04/01/19 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions 3
RSS
  • << Previous
  • 1...
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • ...28
  • Next >>

Get Email Alerts

Stay informed about our latest news and updates

Sign up Today
© 2019Xenetic Biosciences, Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap